20891 ⎘
Medicinal preparations containing peptides Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
PEPTIDE PARTICLES AND METHODS OF FORMATION
#2PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#3BONE TARGETED TREATMENT IN OSTEOGENESIS IMPERFECTA
#4METHODS AND COMPOSITIONS FOR THE TREATMENT OF DEMYELINATING DISORDERS
#5METHODS FOR REDUCING CD36 EXPRESSION
#6Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae
#7Computational Design of Self-Assembling Cyclic Protein Homo-oligomers
#8INHIBITION OF TREM RECEPTOR SIGNALING WITH PEPTIDE VARIANTS
#9PEPTIDES DERIVED FROM KITA-KYUSHU LUNG CANCER ANTIGEN (KKLC1, CT83, CXORF61) AND COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES
#10PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#11METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#12H3.3 CTL PEPTIDES AND USES THEREOF
#13CYSTEINE REACTIVE PEPTIDES
#14Derivative of aspartic acid and use thereof in treatment of metabolic diseases such as hepatic fibrosis and non-alcoholic hepatitis
#15METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES
#16PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#17FORMULATION OF PEPTIDE IMMUNOTHERAPIES
#18COMPOSITIONS, DELIVERY SYSTEMS, AND METHODS USEFUL IN TUMOR THERAPY
#19IMMUNOGENIC PEPTIDES AND THEIR USE IN TRANSPLANTATION
#20SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION
#21ORAL ACTIVE AGENT DELIVERY SYSTEM FOR ANIMALS AND METHOD
#22Food supplement and composition for treating the metabolic syndrome
#23Inhibition of TREM receptor signaling with peptide variants
#24Small Molecule Cancer Treatments that Cause Necrosis in Cancer Cells But Do Not Affect Normal Cells
#25PEPTIDES DERIVED FROM KITA-KYUSHU LUNG CANCER ANTIGEN (KKLC1, CT83, CXORF61) AND COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES
#26METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#27OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT
#28METHODS FOR REDUCING CD36 EXPRESSION
#29PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#30PEPTIDOMIMETIC MACROCYCLES
#31PEPTIDE PARTICLES AND METHODS OF FORMATION
#32COMPOSITIONS HAVING THIOREDOXIN ACTIVITY AND RELATED METHODS
#33PEPTIDE-CONTAINING COMPOSITION FOR USE FOR TREATING NEOPLASTIC LESIONS
#34THERAPEUTIC PEPTIDES
#35TAU PEPTIDE ANTIGENS AND ANTIBODIES BINDING THERETO FOR THE TREATMENT OF TAUOPATHIES
#36FORMULATION FOR ORAL DELIVERY OF PROTEINS, PEPTIDES AND SMALL MOLECULES WITH POOR PERMEABILITY
#37Agents modulating beta-catenin functions and methods thereof
#38Compositions, delivery systems, and methods useful in tumor therapy
#39AMYLOID CONJUGATE AND USES AND METHODS THEREOF
#40A PHARMACEUTICALLY ACTIVE SUBSTANCE
#41FORMULATION FOR ORAL DELIVERY OF PROTEINS, PEPTIDES AND SMALL MOLECULES WITH POOR PERMEABILITY
#42METHODS FOR TREATING TRAUMATIC BRAIN INJURY
#43PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#44H3.3 CTL PEPTIDES AND USES THEREOF
#45MOSQUITOCIDAL XENORHABDUS, LIPOPEPTIDE AND METHODS
#46TREATMENT OF ALZHEIMER'S DISEASE (AD) WITH AN ALUMINUM SALT
#47Compositions and methods relating to salts of specialized pro-resolving mediators
#48METHODS FOR DISRUPTING BIOFILMS
#49PEPTIDOMIMETIC MACROCYCLES
#50PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#51Small Molecule Cancer Treatments that Cause Necrosis in Cancer Cells But Do Not Affect Normal Cells
#52Peptidic TGF-beta antagonists
#53Computational design of self-assembling cyclic protein homo-oligomers
#54Treatment of demyelinating disorders
#55Compositions and methods relating to salts of specialized pro-resolving mediators
#56PEPTIDES DERIVED FROM KITA-KYUSHU LUNG CANCER ANTIGEN (KKLC1, CT83, CXORF61) AND COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES
#57Target for diabetes treatment and prevention
#58Proteins and nucleic acids useful in vaccines targeting
#59PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#60Methods for reducing CD36 expression
#61H3.3 CTL peptides and uses thereof
#62FGF21 C-terminal peptide optimization
#63Treatment of Alzheimer's Disease (AD) with an aluminum salt
#64Food composition
#65Proteasome inhibitors
#66Formulation for oral delivery of proteins, peptides and small molecules with poor permeability
#67MALIGNANT TUMOR TARGET PEPTIDE
#68INHIBITORS
#69Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
#70IMMUNOGENIC PEPTIDES AND THEIR USE IN TRANSPLANTATION
#71Agents modulating beta-catenin functions and methods thereof
#72AMYLOID CONJUGATE AND USES AND METHODS THEREOF
#73Compositions and methods relating to salts of specialized pro-resolving mediators
#74Ratiometric fluorescence imaging methods
#75H3.3 CTL peptides and uses thereof
#76Mosquitocidal Xenorhabdus, Lipopeptide and Methods
#77PEPTIDE-BASED VACCINES, METHODS OF MANUFACTURING, AND USES THEREOF FOR INDUCING AN IMMUNE RESPONSE
#78METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#79SMALL MOLECULE CANCER TREATMENTS THAT CAUSE NECROSIS IN CANCER CELLS BUT DO NOT AFFECT NORMAL CELLS
#80Proteins and nucleic acids useful in vaccines targeting
#81H3.3 CTL peptides and uses thereof
#82Antimicrobial peptide, its analog and use
#83Peptide compounds to regulate the complement system
#84Peptidomimetic macrocycles
#85Methods and compositions for modulating transport of a drug
#86COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING OCULAR DISORDERS
#87Methods of treating inflammatory and autoimmune diseases with natalizumab
#88Prodrugs of Chlorokynurenines
#89Methods for treatment of cancer by targeting SIRT5
#90METHODS FOR REDUCING CD36 EXPRESSION
#91Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
#92Malignant tumor target peptide
#93Computational Design of Self-Assembling Cyclic Protein Homo-oligomers
#94Hair Loss Treatment Compositions and Methods of Making and Using Same
#95Method for treating or/and preventing calcium deficiency-related diseases
#96FGF21 C-TERMINAL PEPTIDE OPTIMIZATION
#97Inhibition of TREM receptor signaling with peptide variants
#98Peptidic TGF-beta antagonists
#99Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
#100Methods for disrupting biofilms
#101AMYLOID CONJUGATE AND USES AND METHODS THEREOF
#102Peptide for cancer treatment and pharmaceutical composition containing same
#103Proteins and nucleic acids useful in vaccines targeting
#104IDENTIFICATION OF CLASS I MHC ASSOCIATED GLYCOPEPTIDES AS TARGETS FOR CANCER IMMUNOTHERAPY
#105NOVEL FUSION POLYPEPTIDE SPECIFIC FOR LAG-3 AND PD-1
#106Derivative Peptide Compounds and Methods of Use
#107Methods and compositions for treatment of demyelinating diseases
#108Methods of sensitizing tumor cells to weak base chemotherapeutic drugs
#109PRODRUGS OF CHLOROKYNURENINES
#110Peptides derived from Kita-kyushu lung cancer antigen (KKLC1, CT83, CXorf61) and complexes comprising such peptides bound to MHC molecules
#111Peptide-induced NK cell activation
#112TUMOR ANTIGEN MODIFIED DENDRITIC CELLS
#113INHIBITION OF TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 (TREM1) TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS
#114Pharmaceutical formulations for the oral delivery of peptide drugs
#115Peptide compounds to regulate the complement system
#116Peptidomimetics for Treating HER2-Overexpressd Cancer
#117CCK2R-drug conjugates
#118Compositions and methods relating to salts of specialized pro-resolving mediators
#119PEPTIDYL TPOR ANTAGONISTS AND USES THEREOF
#120SIZE TUNABLE MICROBIAL MIMETICS FOR IMMUNOTHERAPY OF THYROID CARCINOMAS AND SOLID TUMORS
#121Computational design of self-assembling cyclic protein homo-oligomers
#122Compositions and methods for treating diabetes, hypertension and hypercholesterolemia
#123Compositions comprising TALENs and methods of treating HIV
#124Compositions and methods relating to salts of specialized pro-resolving mediators
#125Methods and compositions for modulating transport of a drug
#126High performance liquid chromatography method for polypeptide mixtures
#127Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide
#128Self-assembling complex for targeting chemical agents to cells
#129PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES
#130Small molecule polypeptide for preventing and restraining inflammation and application of same
#131Products for the delivery of therapeutic/diagnostic compounds to the heart
#132Mosquitocidal xenorhabdus, lipopeptide and methods
#133METHODS FOR REDUCING CD36 EXPRESSION
#134H3.3 CTL peptides and uses thereof
#135Peptidomimetic macrocycles
#136Methods and compositions for diagnosis and treatment of cancer
#137Peptidomimetics for treating HER2-overexpressed cancer
#138Methods of treating inflammatory and autoimmune diseases with natalizumab
#139SPHERICAL MICROCAPSULES WITH ENHANCED ORAL BIOAVAILABILITY
#140SMALL MOLECULE CANCER TREATMENTS THAT CAUSE NECROSIS IN CANCER CELLS BUT DO NOT AFFECT NORMAL CELLS
#141PROCESS FOR MANUFACTURING GLATIRAMER ACETATE PRODUCT
#142SELECTIVE SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND COMBINATION THERAPY THEREWITH
#143RITUXIMAB INDUCTION THERAPY FOLLOWED BY GLATIRAMER ACETATE THERAPY
#144C6S specific transporter molecules
#145Covalent inhibitors of dual oxidase 1 (DUOX 1)
#146Sublingual delivery of glatiramer acetate
#147Anti-lymphoma peptides
#148Treatment of alzheimer'S disease (AD) with an aluminum salt
#149METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB
#150Target for diabetes treatment and prevention
#151Derivative peptide compounds and methods of use
#152Peptide compounds to regulate the complement system
#153DIAGNOSTIC METHODS FOR PAR4 ANTAGONIST THERAPY
#154Ligands to radiation-induced molecules
#155TRANSMUCOSAL DELIVERY OF GLATIRAMER ACETATE
#156Amyloidosis-inhibiting polypeptides and their use
#157BIOACTIVE MOLECULES PRODUCED BY PROBIOTIC BACTERIA AND METHODS FOR ISOLATING AND USING THE SAME
#158Treatment of demyelinating disorders
#159Self-assembling complex for targeting chemical agents to cells
#160Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation
#161Hair loss compositions and methods of making and using same
#162Methods and compositions for treatment of demyelinating diseases
#163Fusion protein comprising granzyme B and use thereof
#164Peptides that stimulate subcutaneous adipogenesis
#165Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#166Immunogenic composition and uses thereof
#167Peptide compounds to regulate the complement system
#168Peptidomimetic macrocycles
#169Peptides that inhibit the interaction between ASF1 and histones, and use thereof
#170Ligands to radiation-induced molecules
#171Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#172TRANSCUTANEOUS DELIVERY OF THERAPEUTIC AGENTS
#173Methods for reducing CD36 expression
#174Methods for treatment of cancer by targeting Sirt5
#175Inhibitors of viral integrase and methods of use
#176Peptides that stimulate subcutaneous adipogenesis
#177Treatments for Alzheimer's disease
#178COMPOSITIONS FOR THE MANAGEMENT OF GLYCATED HEMOGLOBIN AND BLOOD GLUCOSE
#179Food supplement comprising amino acid and chromium
#180Antimicrobial lytic peptides
#181Nanoparticles containing pH-responsive peptide
#182Therapeutic peptides
#183Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#184Treating MUC1-expressing cancers with combination therapies
#185Ligands to radiation-induced molecules
#186Methods for preventing or treating mitochondrial permeability transition
#187Peptides based on the transmembrane domain of a toll-like receptor (TLR) for treatment of TLR-mediated diseases
#188Growth hormone secretatogue receptor antagonists and uses thereof
#189Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#190Peptides that home to atherosclerotic plaques and methods of use
#191Compositions and methods for modulating toll-like receptor 2 activation
#19299mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical
#193Methods for treating depression using NCAM peptide mimetics
#194THERAPEUTIC AGENT FOR PULMONARY SMALL CELL CARCINOMA
#195Inhibition of TREM receptor signaling with peptide variants
#196Inhibitors of viral integrase and methods of use
#197Mosquitocidal Xenorhabdus, Lipopeptide And Methods
#198Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#199Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#200IMMUNOGENIC COMPOSITION AND USES THEREOF
#201Methods for preventing or treating mitochondrial permeability transition
#202Peptides
#203Radiolabeled annexins
#204Drug or dermatological composition containing an avocado peptide extract for treating and preventing pruritus
#205Ligands to radiation-induced molecules
#206Small molecule cancer treatments that cause necrosis in cancer cells but do not affect normal cells
#207Transcutaneous delivery of therapeutic agents
#208Immunogenic peptides and their use in transplantation
#209Immunostimulating agent
#210Composition For Delaying Cellular Senescence
#211Self-assembling complex for targeting chemical agents to cells
#212Methods for reducing CD36 expression
#213Peptides comprising alternating hydrophobic and anionic amino acids for treatment of osteoporosis
#214Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#215Methods of treating inflammatory and autoimmune diseases with natalizumab
#216METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#217Method and composition for inhibiting cardiovascular cell proliferation
#218Tc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical
#219Methods for reducing CD36 expression
#220FGF2-RELATED METHODS FOR DIAGNOSING AND TREATING DEPRESSION
#221Angiotensin (1-7) Dosage Forms and Uses Thereof
#222Methods to treat cancer with cupredoxins
#223Salicylanilides enhance oral delivery of therapeutic peptides
#224Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies
#225CALCIUM BINDING PEPTIDES
#226FGF2-RELATED METHODS FOR DIAGNOSING AND TREATING DEPRESSION
#227Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II
#228Methods for prophylaxis or treatment of conditions associated with cortical spreading depression
#229Agents And Methods For Early Diagnosis And Monitoring Of Alzheimer's Disease And Other Neurological Disorders
#230Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#231Use of Compounds Containing Thiol Groups as Efflux Pump Inhibitors
#232Methods of treating inflammatory and autoimmune diseases with natalizumab
#233Methods for reducing CD36 expression
#234Orally administered small peptides synergize statin activity
#235Methods for preventing or treating ischemia-reperfusion injury of the kidney
#236Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#237Method and composition for inhibiting cardiovascular cell proliferation
#238Method and composition for inhibiting cardiovascular cell proliferation
#239Ligands to radiation-induced molecules
#240Peptides and their use to ameliorate cell death
#241Orally administered small peptides synergize statin activity
#242Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#243Hair-follicle treatment,in particular against hair loss
#244Methods and compositions for modulating transport of a drug
#245Self-assembling amphiphilic peptides
#246Magnetic resonance imaging of self-assembled biomaterial scaffolds